Approval · Notice of Compliance 8642 · 2007
SANDOZ RISPERIDONE: Notice of Compliance 8642
Issued March 8, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8642
- Date
- March 8, 2007
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antipsychotic agent
- Canadian reference product
- RISPERDAL (Janssen-Ortho Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SANDOZ RISPERIDONE | 02292807 | Cancelled Post Market |
Medicinal ingredients
- RISPERIDONE 0.25 MG per TAB